172 related articles for article (PubMed ID: 38070928)
21. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.
Wang T; Huang YY; Liu XL; Molassiotis A; Yao LQ; Zheng SL; Tan JB; Huang HQ
Support Care Cancer; 2022 Nov; 30(11):9279-9288. PubMed ID: 36065027
[TBL] [Abstract][Full Text] [Related]
22. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.
Lustberg MB; Orchard TS; Reinbolt R; Andridge R; Pan X; Belury M; Cole R; Logan A; Layman R; Ramaswamy B; Wesolowski R; Berger M; Patterson E; Loprinzi C; Shapiro CL; Yee L
Breast Cancer Res Treat; 2018 Feb; 167(3):709-718. PubMed ID: 29101597
[TBL] [Abstract][Full Text] [Related]
23. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL
Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.
Hershman DL; Unger JM; Greenlee H; Capodice J; Lew DL; Darke A; Minasian LM; Fisch MJ; Henry NL; Crew KD
JAMA Netw Open; 2022 Nov; 5(11):e2241720. PubMed ID: 36367721
[TBL] [Abstract][Full Text] [Related]
25. Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
Crew KD; Capodice JL; Greenlee H; Apollo A; Jacobson JS; Raptis G; Blozie K; Sierra A; Hershman DL
J Cancer Surviv; 2007 Dec; 1(4):283-91. PubMed ID: 18648963
[TBL] [Abstract][Full Text] [Related]
26. Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.
Baglia ML; Lin IH; Cartmel B; Sanft T; Ligibel J; Hershman DL; Harrigan M; Ferrucci LM; Li FY; Irwin ML
Cancer; 2019 Jul; 125(13):2262-2271. PubMed ID: 30840336
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Gnant M; Pfeiler G; Steger GG; Egle D; Greil R; Fitzal F; Wette V; Balic M; Haslbauer F; Melbinger-Zeinitzer E; Bjelic-Radisic V; Jakesz R; Marth C; Sevelda P; Mlineritsch B; Exner R; Fesl C; Frantal S; Singer CF;
Lancet Oncol; 2019 Mar; 20(3):339-351. PubMed ID: 30795951
[TBL] [Abstract][Full Text] [Related]
28. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
Chim K; Xie SX; Stricker CT; Li QS; Gross R; Farrar JT; DeMichele A; Mao JJ
BMC Cancer; 2013 Sep; 13():401. PubMed ID: 24004677
[TBL] [Abstract][Full Text] [Related]
29. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Mamounas EP; Bandos H; Lembersky BC; Jeong JH; Geyer CE; Rastogi P; Fehrenbacher L; Graham ML; Chia SK; Brufsky AM; Walshe JM; Soori GS; Dakhil SR; Seay TE; Wade JL; McCarron EC; Paik S; Swain SM; Wickerham DL; Wolmark N
Lancet Oncol; 2019 Jan; 20(1):88-99. PubMed ID: 30509771
[TBL] [Abstract][Full Text] [Related]
30. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
Galantino ML; Desai K; Greene L; Demichele A; Stricker CT; Mao JJ
Integr Cancer Ther; 2012 Dec; 11(4):313-20. PubMed ID: 21733988
[TBL] [Abstract][Full Text] [Related]
31. Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors.
Mao JJ; Bruner DW; Stricker C; Farrar JT; Xie SX; Bowman MA; Pucci D; Han X; DeMichele A
Integr Cancer Ther; 2009 Jun; 8(2):123-9. PubMed ID: 19679620
[TBL] [Abstract][Full Text] [Related]
32. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
[TBL] [Abstract][Full Text] [Related]
34. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial.
Peng N; Yu M; Yang G; Fu Q; Xu Y; Yu J; Liu Q; Li C; Xu W; Zhang Y; Ma C; Yang L; Yu R; Wang X
Breast; 2018 Feb; 37():18-27. PubMed ID: 29059538
[TBL] [Abstract][Full Text] [Related]
35. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
[TBL] [Abstract][Full Text] [Related]
36. Acupuncture for Arthralgia Induced by Aromatase Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis.
Liu X; Lu J; Wang G; Chen X; Xv H; Huang J; Xue M; Tang J
Integr Cancer Ther; 2021; 20():1534735420980811. PubMed ID: 33586504
[TBL] [Abstract][Full Text] [Related]
37. Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
Shenouda M; Copley R; Pacioles T; Lebowicz Y; Jamil M; Akpanudo S; Tirona MT
Clin Breast Cancer; 2022 Jan; 22(1):e30-e36. PubMed ID: 34275765
[TBL] [Abstract][Full Text] [Related]
38. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Saad F; Thiery-Vuillemin A; Wiechno P; Alekseev B; Sala N; Jones R; Kocak I; Chiuri VE; Jassem J; Fléchon A; Redfern C; Kang J; Burgents J; Gresty C; Degboe A; Clarke NW
Lancet Oncol; 2022 Oct; 23(10):1297-1307. PubMed ID: 36063830
[TBL] [Abstract][Full Text] [Related]
39. Auricular Point Acupressure to Manage Aromatase Inhibitor-Induced Arthralgia in Postmenopausal Breast Cancer Survivors: A Pilot Study.
Yeh CH; Lin WC; Kwai-Ping Suen L; Park NJ; Wood LJ; van Londen GJ; Howard Bovbjerg D
Oncol Nurs Forum; 2017 Jul; 44(4):476-487. PubMed ID: 28632237
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
Cathcart-Rake E; Novotny P; Leon-Ferre R; Le-Rademacher J; Storrick EM; Adjei AA; Terstriep S; Glaser R; Giuliano A; Mitchell WR; Page S; Austin C; Deming RL; Ferreira MA; Lafky JM; Birrell SN; Loprinzi CL
Support Care Cancer; 2021 Jan; 29(1):387-396. PubMed ID: 32372176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]